IRIS
MIELE, GIUSEPPINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 249
EU - Europa 231
AS - Asia 82
AF - Africa 3
OC - Oceania 1
Totale 566
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 249
IE - Irlanda 104
IT - Italia 59
SG - Singapore 53
DE - Germania 29
CN - Cina 18
FI - Finlandia 9
GB - Regno Unito 7
CZ - Repubblica Ceca 5
IN - India 5
KR - Corea 5
BE - Belgio 4
NL - Olanda 4
AT - Austria 3
MA - Marocco 3
SE - Svezia 3
AU - Australia 1
FR - Francia 1
GR - Grecia 1
JP - Giappone 1
LU - Lussemburgo 1
RU - Federazione Russa 1
Totale 566
Salva come PNG Salva come JPEG
Città #
Dublin 104
Santa Clara 58
Singapore 46
Chandler 33
New York 22
Munich 17
Naples 16
Cambridge 13
Boardman 10
Roxbury 9
Princeton 8
Helsinki 7
Pasadena 6
Beijing 5
Brno 5
Milan 5
Seoul 5
Bremen 4
Brussels 4
Aversa 3
Bari 3
Meknes 3
Norwich 3
Pune 3
Rockville 3
Amsterdam 2
Ann Arbor 2
Ashburn 2
Hyderabad 2
Lappeenranta 2
Vienna 2
Atlanta 1
Battipaglia 1
Frankfurt am Main 1
Grafing 1
Los Angeles 1
Luxembourg 1
L’Aquila 1
Medford 1
Moscow 1
Napoli 1
New Haven 1
Norwalk 1
Nuremberg 1
Pognano 1
Putignano 1
Quarto 1
Recanati 1
Romola 1
Sala Consilina 1
Shenyang 1
Sulmona 1
Tokyo 1
Wilmington 1
Woodbridge 1
Wuhan 1
Totale 432
Salva come PNG Salva come JPEG
Nome #
Myasthenia gravis and telemedicine: a lesson from COVID-19 pandemic 55
Telemedicine application to headache: a critical review 52
Lymphopenia in Multiple Sclerosis patients treated with Ocrelizumab is associated with an effect on CD8 T cells 40
Multiple sclerosis and genetic polymorphisms in fibrinogen-mediated hemostatic pathways: a case–control study 33
Source of medical information and behavioral seeking patterns in patients affected with Friedreich’s ataxia and their caregivers: a survey study 33
Prognostic Markers of Ocrelizumab Effectiveness in Multiple Sclerosis: A Real World Observational Multicenter Study 30
Association between relapses, stress, and depression in people with multiple sclerosis during the COVID-19 pandemic 29
Disease Reactivation in Secondary Progressive Multiple Sclerosis Patients Switching from Fingolimod to Siponimod: A Case Series 27
Immunomodulatory effects of ocrelizumab and candidate biomarkers for monitoring treatment response in multiple sclerosis 26
Expectations for the high-energy neutrino detection from starburst galaxies with KM3NeT/ARCA 25
Optimal retreatment schedule of rituximab for neuromyelitis optica spectrum disorder: A systematic review 23
Telemedicine for management of patients with amyotrophic lateral sclerosis through COVID-19 tail 22
Health related quality of life in the domain of physical activity predicts confirmed disability progression in people with relapsing remitting multiple sclerosis 19
Alemtuzumab-Related Lymphocyte Subset Dynamics and Disease Activity or Autoimmune Adverse Events: Real-World Evidence 18
MRI and steroid-responsive encephalopathy associated with autoimmune thyroiditis: first report of conus medullaris involvement and literature review of the known neuroimaging profiles 18
Clinically Manifest Infections Do Not Increase the Relapse Risk in People with Multiple Sclerosis Treated with Disease-Modifying Therapies: A Prospective Study 17
Viral pericarditis following ocrelizumab in a multiple sclerosis patient 15
Association of vitamin D serum levels and vitamin D supplementation with B cell kinetics and disease activity in Multiple Sclerosis patients treated with ocrelizumab: an Italian multi-center study 14
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study 14
COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context 12
Pain, quality of life, and religiosity in people with multiple sclerosis 12
Dermatological Neoplastic Diseases Complicating Treatment with Monoclonal Antibodies for Multiple Sclerosis 12
Clinical implications for the association of psoriasis and multiple sclerosis: an observational study 10
Validation of the swallowing disturbance questionnaire in people with multiple sclerosis 10
Ocrelizumab and ofatumumab comparison: an Italian real-world propensity score matched study 9
ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings and perceived empathy in responses among people living with multiple sclerosis 9
Identifying definite patterns of unmet needs in patients with multiple sclerosis using unsupervised machine learning 9
Previous disease-modifying treatments influence T lymphocyte kinetics in people with multiple sclerosis switching to ocrelizumab 5
Ocrelizumab Alters Cytotoxic Lymphocyte Function While Reducing EBV-Specific CD8 + T-Cell Proliferation in Patients With Multiple Sclerosis 3
Hydranencephaly in CENPJ-related Seckel syndrome 2
Totale 603
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.666
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.666
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215 0 0 0 3 1 0 0 0 0 0 1 0
2021/202259 0 0 3 2 6 4 0 1 2 0 13 28
2022/2023178 29 7 2 3 9 9 1 7 91 4 7 9
2023/2024189 10 12 13 14 35 32 11 1 5 1 7 48
2024/2025172 2 9 4 50 107 0 0 0 0 0 0 0
Totale 603